News Conference News ESC 2021 New ESC Prevention Guidelines Focus on Tailored, Escalating Therapy Michael O'Riordan September 03, 2021
News Conference News ESC 2021 No Attenuation in CVD Risk Reduction for Patients Treated to Very Low LDLs: FOURIER Michael O'Riordan September 02, 2021
News Conference News ESC 2021 Fixed-Dose Combo Therapy Slashes CVD Risk in Primary Prevention Michael O'Riordan August 31, 2021
News Conference News ESC 2021 PRONOUNCE: No Difference in CVD Risks With Degarelix and Leuprolide for Prostate Cancer Michael O'Riordan August 30, 2021
News Conference News ESC 2021 Studies Reveal Surprising Benefits of Smoking Cessation and ‘Greenness’ L.A. McKeown August 28, 2021
News Conference News ESC 2021 Finerenone Reduces CV Outcomes in Patients With Early CKD, Diabetes: FIGARO-DKD Michael O'Riordan August 28, 2021
News Conference News ESC 2021 SMART-MI: Implant IDs Large Burden of Arrhythmic Events Post-MI Michael O'Riordan August 27, 2021
News Features Expired Cardiac Devices May Do Global Good, but Safety Unknown Yael L. Maxwell August 26, 2021
News Opinion Editor's Corner ESC 2021 ESC 2021: Trials, Guidelines, and Channel Surfing at This Year’s Virtual Congress Shelley Wood August 19, 2021
News Daily News Endpoint Reporting in Medical Journals Needs to Be Revamped: Review Michael O'Riordan August 17, 2021
News Daily News MRI of Vaccine-Induced Myocarditis Yields New Theories, Questions Michael O'Riordan August 11, 2021
News Daily News Myocarditis, Pericarditis Rare After COVID-19 Vaccination: EMR Data Michael O'Riordan August 05, 2021
News Daily News Therapeutic-Dose Heparin in COVID-19: Who Benefits, Who Doesn’t Shelley Wood August 04, 2021
News Daily News MitraClip Viable in Shock Patients With Significant MR: Observational Study Michael O'Riordan July 29, 2021
News Conference News HRS 2021 J-Curve for Alcohol and AF Risk? UK Biobank Offers ‘Glimmer of Hope’ Shelley Wood July 28, 2021
News Daily News Coffee Doesn’t Disturb Heart Rhythm: UK Biobank Analysis Caitlin E. Cox July 22, 2021